Access the updated page using the API Locator.   Our Custom Search for Pharma News…

FDA Approval Activities for this Drug… Ethosuximide Capsules, 250 mg, Banner Pharmacaps ANDA 40-430 10/28/02 | Ethosuximide Syrup,250 mg/5 mL, Pharmaceutical Associates, ANDA 40-253 | Zarontin (ethosuximide) Capsules, Pfizer NDA 12-380/S29 4/19/02 5/2/02 | Zarontin (ethosuximide) 250 mg Capsules and 250 mg/5 ml Syrup. Parket-Davis NDA 12380/S-22/23/25 | ETHOSUXIMIDE Capsule; 250MG ETHOSUXIMIDE BANNER PHARMACAPS | 012380 ETHOSUXIMIDE Capsule; 250MG ZARONTIN PARKE DAVIS | 081306 ETHOSUXIMIDE Syrup; 250MG/5ML ETHOSUXIMIDE Copley | 080258 ETHOSUXIMIDE Syrup; 250MG/5ML ZARONTIN PARKE DAVIS | 040253 ETHOSUXIMIDE Syrup; 250MG/5ML ETHOSUXIMIDE ASSOC | Zarontin Capsules, Pfizer, Labeling Supplement | Ethosuximide Capsules, Covenant Pharma, Inc., Approval | Zarontin (ethosuximide) Capsules, Pfizer, Inc., Labeling Revision | Zarontin (ethosuximide) Capsules, Pfizer, Inc., Labeling Revision | Zarontin (ethosuximide) Capsules, Pfizer, Inc., Labeling Revision View updates.                                                                       A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U-Z Health Topics | For Industry | DMF Index | Pharma Job Search | Pharma Company News | VOIP © 2012 Betterchem.com